Behavioral studies relevant to vaccine trial preparation: an introduction. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Behavioral studies relevant to vaccine trial preparation: an introduction.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S273-6. Unique Identifier : AIDSLINE MED/95169498
Turner CF; Sheon AR; Program in Health and Behavior Measurement, Research Triangle; Institute, Rockville, Maryland 20852.


Abstract: Preparations for large-scale trials to test the efficacy of candidate HIV vaccines can benefit in several crucial ways from a targeted program of behavioral and social research. Randomized field experiments testing alternative procedures for the recruitment and retention of subjects can help identify research procedures that will ensure adequate sample sizes while minimizing sample attrition over time. Similarly, assuring that subjects accurately comprehend the potential risks of participation will require more than simply presenting scientifically accurate information. Ensuring both the adequacy and appropriateness of risk communications as well as the accuracy of subject perception of risks (across the social and cultural milieux in which vaccine trials will be undertaken) is a critical task. Ethnographic and behavioral studies can help to ensure that our obligation to obtain truly informed consent from our research subjects is fully met and documented. Monitoring risk behaviors over the course of the vaccine trials could also benefit from strategic investments in new technologies developed by social researchers to permit the collection of sensitive personal data while affording complete privacy to subjects. These new measurement technologies include procedures that permit private data collection (without a human interviewer) in any spoken language and without requiring that subjects be literate.
Keywords: AIDS Vaccines/*PHARMACOLOGY Clinical Trials/*METHODS/*PSYCHOLOGY Female Human HIV Infections/*PREVENTION & CONTROL/*PSYCHOLOGY/TRANSMISSION Informed Consent Male Patient Selection Questionnaires Risk-Taking Sex Behavior JOURNAL ARTICLEKWDaidsvaccines/KWDpharmacologyclinicaltrials/KWDmethods/KWDpsychologyfemalehumanhivinfections/KWDprevention&control/KWDpsychology/transmissioninformedconsentmalepatientselectionquestionnairesrisk-takingsexbehaviorjournalarticle
950630
M9561118

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .